Placenta
Volume 31 , Pages S60-S65 , March 2010

Review: Placental Programming of Postnatal Diabetes and Impaired Insulin Action after IUGR

  • K.L. Gatford

      Affiliations

    • Research Centre for Early Origins of Health and Disease, Robinson Institute, and School of Paediatrics and Reproductive Health, University of Adelaide, SA 5005, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 8 8303 4158; fax: +61 8 8303 4099.
    • ,
  • R.A. Simmons

      Affiliations

    • Department of Pediatrics, School of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • ,
  • M.J. De Blasio

      Affiliations

    • Research Centre for Early Origins of Health and Disease, Robinson Institute, and School of Paediatrics and Reproductive Health, University of Adelaide, SA 5005, Australia
    • ,
  • J.S. Robinson

      Affiliations

    • Research Centre for Early Origins of Health and Disease, Robinson Institute, and School of Paediatrics and Reproductive Health, University of Adelaide, SA 5005, Australia
    • ,
  • J.A. Owens

      Affiliations

    • Research Centre for Early Origins of Health and Disease, Robinson Institute, and School of Paediatrics and Reproductive Health, University of Adelaide, SA 5005, Australia

,Accepted 14 December 2009.

References 

  1. Newsome CA, Shiell AW, Fall CHD, Phillips DIW, Shier R, Law CM. Is birth weight related to later glucose and insulin metabolism? – a systemic review. Diabet Med. 2003;20:339–348
  2. Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A. Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. Am J Epidemiol. 2007;165(8):849–857
  3. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA. 2008;300(24):2886–2897
  4. Kaijser M, Edstedt Bonamy A-K, Akre O, Cnattingius S, Granath F, Norman M, et al. Perinatal risk factors for diabetes in later life. Diabetes. 2009;58(3):523–526
  5. Eriksson M, Wallander M-A, Krakau I, Wedel H, Svardsudd K. Birth weight and cardiovascular risk factors in a cohort followed until 80 years of age: the study of men born in 1913. J Intern Med. 2004;255(2):236–246
  6. Ong KKL, Ahmed ML, Emmett PM, Preece MA, Dunger DB. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. Br Med J. 2000;320:967–971
  7. Belfiore F, Iannello S. Insulin resistance in obesity: metabolic mechanisms and measurement methods. Mol Genet Metab. 1998;65:121–128
  8. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of β-cell function. The hyperbolic correction. Diabetes. 2002;51(Suppl. 1):S212–S220
  9. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab. 2000;85:1401–1406
  10. Bazaes RA, Salazar TE, Pittaluga E, Pena V, Alegria A, Iniguez G, et al. Glucose and lipid metabolism in small for gestational age infants at 48 hours of age. Pediatrics. 2003;111:804–809
  11. Soto N, Bazaes RA, Pena V, Salazar TE, Avila A, Iniguez G, et al. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab. 2003;88:3645–3650
  12. Ong KK, Petry CJ, Emmett PM, Sandhu MS, Kiess W, Hales CN, et al. Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia. 2004;47:1064–1070
  13. Mericq V, Ong KK, Bazaes R, Pena V, Avila A, Salazar T, et al. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children. Diabetologia. 2005;48:2609–2614
  14. Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA. Early differential defects of insulin secretion and action in 19-year-old Caucasian men who had low birth weight. Diabetes. 2002;51:1271–1280
  15. Veening MA, van Weissenbruch MM, Heine RJ, Delemarre-van de Waal HA. β-cell capacity and insulin sensitivity in prepubertal children born small for gestational age. Influence of body size during childhood. Diabetes. 2003;52:1756–1760
  16. Myatt L. Placental adaptive responses and fetal programming. J Physiol. 2006;572(1):25–30
  17. Risnes KR, Romundstad PR, Nilsen TIL, Eskild A, Vatten LJ. Placental weight relative to birth weight and long-term cardiovascular mortality: findings from a cohort of 31,307 men and women. Am J Epidemiol. 2009;170(5):622–631
  18. Steven DH. Anatomy of the placental barrier. In:  Steven DH editors. Comparative placentation: essays in structure and function. London: Academic Press; 1975;p. 25–57
  19. Enders AC, Carter AM. What can comparative studies of placental structure tell us? – a review. Placenta. 2004;25(Suppl. 1):S3–S9
  20. Alexander GR. Studies on the placenta of the sheep (Ovis aries L.). Effect of surgical reduction in the number of caruncles. J Reprod Fertil. 1964;7:307–322
  21. Robinson JS, Kingston EJ, Jones CT, Thorburn GD. Studies on experimental growth retardation in sheep. The effect of removal of endometrial caruncles on fetal size and metabolism. J Dev Physiol. 1979;1:379–398
  22. Harding JE, Jones CT, Robinson JS. Studies on experimental growth restriction in sheep. The effects of a small placenta in restricting transport to and growth of the fetus. J Dev Physiol. 1985;7:427–442
  23. Owens JA, Falconer J, Robinson JS. Restriction of placental size in sheep enhances efficiency of placental transfer of antipyrine, 3-O-methyl-d-glucose but not of urea. J Dev Physiol. 1987;9:457–464
  24. Owens JA, Falconer J, Robinson JS. Effect of restriction of placental growth on umbilical and uterine blood flows. Am J Physiol. 1986;250:R427–R434
  25. Owens JA, Falconer J, Robinson JS. Effect of restriction of placental growth on oxygen delivery to and consumption by the pregnant uterus and fetus. J Dev Physiol. 1987;9:137–150
  26. Owens JA, Falconer J, Robinson JS. Effect of restriction of placental growth on fetal and utero-placental metabolism. J Dev Physiol. 1987;9:225–238
  27. Owens JA, Falconer J, Robinson JS. Glucose metabolism in pregnant sheep when placental growth is restricted. Am J Physiol. 1989;257:R350–R357
  28. Jones CT, Boddy K, Robinson JS. Changes in the concentration of adrenocorticotrophin and corticosteroid in the plasma of foetal sheep in the latter half of pregnancy and during labour. J Endocrinol. 1977;72:293–300
  29. Owens JA, Kind KL, Carbone F, Robinson JS, Owens PC. Circulating insulin-like growth factors-I and -II and substrates in fetal sheep following restriction of placental growth. J Endocrinol. 1994;140:5–13
  30. Kind KL, Owens JA, Robinson JS, Quinn KJ, Grant PA, Walton PE, et al. Effect of restriction of placental growth on expression of IGFs in fetal sheep: relationship to fetal growth, circulating IGFs and binding proteins. J Endocrinol. 1995;146:23–34
  31. Phillips ID, Simonetta G, Owens JA, Robinson JS, Clarke IJ, McMillen C. Placental restriction alters the functional development of the pituitary–adrenal axis in the sheep fetus during late gestation. Pediatr Res. 1996;40:861–866
  32. Albertsson-Wikland K, Karlberg J. Postnatal growth of children born small for gestational age. Acta Paediatr Suppl. 1997;423:193–195
  33. De Blasio MJ, Gatford KL, Robinson JS, Owens JA. Placental restriction of fetal growth reduces size at birth and alters postnatal growth, feeding activity and adiposity in the young lamb. Am J Physiol. 2007;292:R875–R886
  34. De Blasio MJ, Gatford KL, McMillen IC, Robinson JS, Owens JA. Placental restriction of fetal growth increases insulin action, growth and adiposity in the young lamb. Endocrinology. 2007;148:1350–1358
  35. Gatford KL, Mohammad SNB, Harland ML, De Blasio MJ, Fowden AL, Robinson JS, et al. Impaired β-cell function and inadequate compensatory increases in β-cell mass following intrauterine growth restriction in sheep. Endocrinology. 2008;149:5118–5127
  36. Owens JA, Gatford KL, De Blasio MJ, Edwards LJ, McMillen IC, Fowden AL. Restriction of placental growth in sheep impairs insulin secretion but not sensitivity before birth. J Physiol. 2007;584:935–949
  37. Owens JA, Thavaneswaran P, De Blasio MJ, McMillen IC, Robinson JS, Gatford KL. Sex-specific effects of placental restriction on components of the metabolic syndrome in young adult sheep. Am J Physiol. 2007;292:E1879–E1889
  38. Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol. 2000;24(3):297–302
  39. Owens JA, Harland ML, De Blasio MJ, Gatford KL, Robinson JS. Restriction of placental and fetal growth reduces expression of insulin signalling and glucose transporter genes in skeletal muscle of young lambs. Early Hum Dev. 2007;83:S134;[abstract]
  40. Wigglesworth J. Experimental growth retardation in the foetal rat. J Pathol Bacteriol. 1964;88:1–13
  41. Bruce NW. The effect on fetal development and utero-placental blood flow of ligating a uterine artery in the rat near term. Teratology. 1977;16:327–331
  42. Nitzan M, Orloff S, Schulman JD. Placental transfer of analogs of glucose and amino acids in experimental intrauterine growth retardation. Pediatr Res. 1979;13:100–103
  43. Vileisis RA, D'Ercole AJ. Tissue and serum concentrations of somatomedin-C/insulin-like growth factor I in fetal rats made growth retarded by uterine artery ligation. Pediatr Res. 1986;20:126–130
  44. De Prins FA, Van Assche FA. Intrauterine growth retardation and development of endocrine pancreas in the experimental rat. Biol Neonate. 1982;41:16–21
  45. Simmons RA, Templeton LJ, Gertz SJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes. 2001;50:2279–2286
  46. Nusken K-D, Dotsch J, Rauh M, Rascher W, Schneider H. Uteroplacental insufficiency after bilateral uterine artery ligation in the rat: impact on postnatal glucose and lipid metabolism and evidence for metabolic programming of the offspring by sham operation. Endocrinology. 2008;149(3):1056–1063
  47. Siebel AL, Mibus AL, De Blasio MJ, Westcott KT, Morris MJ, Prior L, et al. Improved lactational nutrition and postnatal growth ameliorates impairment of glucose tolerance by uteroplacental insufficiency in male rat offspring. Endocrinology. 2008;149(6):3067–3076
  48. Albertsson-Wikland K, Karlberg J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Suppl. 1994;399:64–70
  49. Karlberg JPE, Albertsson-Wikland K, Kwan EYW, Lam BCC, Low LCK. The timing of early postnatal catch-up growth in normal, full-term infants born short for gestational age. Horm Res. 1997;48(Suppl. 1):17–24
  50. Jansson T, Lambert GW. Effect of intrauterine growth restriction on blood pressure, glucose tolerance and sympathetic nervous system activity in the rat at 3–4 months of age. J Hypertens. 1999;17:1239–1248
  51. Simmons RA. Developmental origins of beta-cell failure in type 2 diabetes: the role of epigenetic mechanisms. Pediatr Res. 2007;61:64R–67R
  52. MacLennan NK, James SJ, Melnyk S, Piroozi A, Jernigan S, Hsu JL, et al. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiol Genomics. 2004;18:43–50
  53. Ke X, Lei Q, James SJ, Kelleher SL, Melnyk S, Jernigan S, et al. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiological Genomics. 2006;25(1):16–28
  54. Park JH, Stoffers D, Nicholls RD, Simmons RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest. 2008;118:2316–2324
  55. Simmons RA, Suponitsky-Kroyter I, Selak MA. Progressive accumulation of mitochondrial DNA mutations and decline in mitochondrial function lead to β-cell failure. J Biol Chem. 2005;280:28785–28791
  56. Vuguin P, Raab E, Liu B, Barzilai N, Simmons R. Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation. Diabetes. 2004;53:2617–2622
  57. Lane RH, MacLennan NK, Hsu JL, Janke SM, Pham TD. Increased hepatic Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 gene expression in a rat model of intrauterine growth retardation and subsequent insulin resistance. Endocrinology. 2002;143(7):2486–2490
  58. Germani D, Puglianiello A, Cianfarani S. Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth. Cardiovasc Diabetol. 2008;7(1):14
  59. Lane RH, Maclennan NK, Daood MJ, Hsu JL, Janke SM, Pham TD, et al. IUGR alters postnatal rat skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1 gene expression in a fiber specific manner. Pediatr Res. 2003;53:994–1000
  60. Nauck MA, Meier JJ. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes. Regul Pept. 2005;128(2):135–148
  61. Doyle ME, Egan JM. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther. 2007;113(3):546–593
  62. Stoffers DA, Desai BM, De Leon DD, Simmons RA. Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes. 2003;52:734–740
  63. Pinney SE, Niu H, Li F, Simmons RA. Neonatal exendin-4 administration normalises epigenetic modifications of the proximal promoter of Pdx-1. Early Hum Dev. 2007;83(Suppl. 1):S71
  64. Gatford KL, Sulaiman SA, Mohammad SNB, De Blasio MJ, Harland ML, Owens JA. Interventions to prevent diabetes after IUGR – preliminary outcomes in the twin IUGR lamb. Fetal and Neonatal Physiology Workshop, Darwin. 2009.
  65. Willes RF, Boda JM, Stokes H. Cytological localization of insulin and insulin concentration in the fetal ovine pancreas. Endocrinology. 1969;84:671–675
  66. Bassett JM. Glucagon, insulin and glucose homeostasis in the fetal lamb. Ann Rech Vet. 1977;8(4):362–373
  67. Fowden AL. Effects of arginine and glucose on the release of insulin in the sheep fetus. J Endocrinol. 1980;85:121–129
  68. Reddy S, Elliot RB. Ontogenic development of peptide hormones in the mammalian fetal pancreas. Experientia. 1988;44:1–9
  69. Otonkoski T, Andersson S, Knip M, Simell O. Maturation of insulin response to glucose during human fetal and neonatal development. Studies with perfusion of pancreatic islet like cell clusters. Diabetes. 1988;37(3):286–291
  70. Kassem S, Ariel I, Thornton P, Scheimberg I, Glaser B. β-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes. 2000;49(8):1325–1333
  71. Piper K, Brickwood S, Turnpenny LW, Cameron IT, Ball SG, Wilson DI, et al. Beta cell differentiation during early human pancreas development. J Endocrinol. 2004;181(1):11–23
  72. Limesand SW, Jensen J, Hutton JC, Hay WW. Diminished β-cell replication contributes to reduced β-cell mass in fetal sheep with intrauterine growth restriction. Am J Physiol. 2005;288(5):R1297–R1305
  73. Rozance PJ, Limesand SW, Hay WW. Decreased nutrient-stimulated insulin secretion in chronically hypoglycemic late-gestation fetal sheep is due to an intrinsic islet defect. Am J Physiol. 2006;291(2):E404–E411
  74. Scaglia L, Cahill CJ, Finegood DT, Bonner-Weir S. Apoptosis participates in the remodelling of the endocrine pancreas in the neonatal rat. Endocrinology. 1997;138:1736–1741
  75. Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, Bispham J, et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc Natl Acad Sci U S A. 2007;104(49):19351–19356
  76. Gatford KL, Mohammad SNB, Sulaiman SA, De Blasio MJ, Harland ML, Owens JA. Effects of maternal folate supplementation in late pregnancy on insulin sensitivity and β-cell number in the IUGR lamb. Adelaide, Australia: Australian Diabetes Society Annual Scientific Meeting; 2009;p. 264[abstract]

PII: S0143-4004(09)00405-6

doi: 10.1016/j.placenta.2009.12.015

Placenta
Volume 31 , Pages S60-S65 , March 2010

Article Tools

* Image Usage & Resolution